Attached files

file filename
EX-10.1 - EX-10.1 - CANTEL MEDICAL LLCa14-24255_1ex10d1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)  November 6, 2014

 

CANTEL MEDICAL CORP.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-31337

 

22-1760285

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

150 Clove Road, Little Falls, New Jersey

 

07424

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (973) 890-7220

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o         Written communications pursuant to Rule 425 under the Securities  Act (17 CFR 230.425)

 

o         Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o         Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o         Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.02              Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On November 6, 2014, the Board of Directors (the “Board”) of Cantel Medical Corp. (the “Company”), upon the recommendation of its Compensation Committee, approved certain amendments to the Cantel Medical Corp. Annual Incentive Compensation Plan (the “AIC Plan”). The amendments to the AIC Plan were made primarily to revise the range of target incentive award (expressed as a percentage of base salary) available for each executive position.  As a result of the amendments, the range of target incentive awards are now as follows:

 

ELIGIBLE POSITION

 

TARGET INCENTIVE AWARD

CEO

 

90% - 110%

President, COO

 

70% - 80%

Division CEO, Executive Vice President

 

50% - 60%

Senior Vice President

 

45% - 55%

Vice Presidents

 

25% - 40%

 

A copy of the AIC Plan, as revised, is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 9.01                                           Financial Statements and Exhibits

 

(d)           Exhibits

 

The following exhibits are filed herewith:

 

Exhibit

 

Exhibit No.

 

Exhibit Description

10.1

 

Cantel Medical Corp. Annual Incentive Compensation Plan, as amended November 6, 2014.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

CANTEL MEDICAL CORP.

 

(Registrant)

 

 

 

 

 

By:

/s/ Andrew A. Krakauer

 

 

Andrew A. Krakauer,

 

 

President and Chief Executive Officer

 

 

Date: November 12, 2014

 

 

3



 

Exhibit Index

 

Exhibit No.

 

Exhibit Description

 

 

 

10.1

 

Cantel Medical Corp. Annual Incentive Compensation Plan, as amended November 6, 2014.

 

4